Flexible Partnership Models.
Our platform enables diverse therapeutic applications. We collaborate with leading pharmaceutical and biotechnology companies through flexible partnership models — from platform out-licensing and co-development to asset out-licensing.
Platform
Out-licensing
Co-development
Asset Out-licensing
What We Bring to a Partnership.
Get StartedOptimize Therapeutic Window
mRNA-LNP platforms enable differentiated tolerability, specificity, efficacy and manufacturability
Accelerate Execution
Fully vertically integrated in-house capabilities from IP innovation through cGMP manufacturing
Minimize Development Risk
Flexible partnership models aligned with your priorities
